nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ALG9-CDG: New clinical case and review of the literature
|
Davis, Kellie |
|
2017 |
13 |
C |
p. 55-63 9 p. |
artikel |
2 |
A novel nonsense ATP7A pathogenic variant in a family exhibiting a variable occipital horn syndrome phenotype
|
Bonati, Maria Teresa |
|
2017 |
13 |
C |
p. 14-17 4 p. |
artikel |
3 |
A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease
|
Lim, Han-Hyuk |
|
2017 |
13 |
C |
p. 18-22 5 p. |
artikel |
4 |
Comments on: Kocova M, Anastasovska V. Comments on ‘Newborn screening in southeastern Europe’ published in Molecular Genetics and Metabolism, 2014 Sept–Oct;113(1–2):42–45 by U. Groselj, M. ZerjavTansek, A. Smon, N. Angelkova, D. Anton, I. Baric, M. Djordjevic, L. Grimci, M. Ivanova, A. Kadam, V. Mulliqi Kotori, H. Maksic, O. Marginean, O. Margineanu, O. Milijanovic, F. Moldovanu, M. Muresan, S. Murko, M. Nanu, B. Repic Lampert, M. Samardzic, V. Sarnavka, A. Savov, M. Stojiljkovic, B. Suzic, R. Tincheva, H. Tahirovic, A. Toromanovic, N. Usurela, T. Battelino. Mol Genet Metab Rep. 2015 Nov 12;5:110. doi: 10.1016/j.ymgmr.2015.11.003. eCollection 2015 Dec. Journal: Molecular Genetics and Metabolism Reports
|
Gucev, Z. |
|
2017 |
13 |
C |
p. 13- 1 p. |
artikel |
5 |
Confirmation that MAT1A p.Ala259Val mutation causes autosomal dominant hypermethioninemia
|
Muriello, Michael J. |
|
2017 |
13 |
C |
p. 9-12 4 p. |
artikel |
6 |
Correspondence to: “Heterozygous mutation in the X chromosomal NDUFA1 gene in a girl with complex I deficiency” and “A novel NDUFA1 mutation leads to progressive mitochondrial complex I- specific neurodegenerative disease”
|
Xu, Jack Junchi |
|
2017 |
13 |
C |
p. 30- 1 p. |
artikel |
7 |
Costs for mitochondrial medicine will remain high as long as mitochondrial disorders are misdiagnosed
|
Finsterer, Josef |
|
2017 |
13 |
C |
p. 41- 1 p. |
artikel |
8 |
Dietary management of maternal phenylketonuria with glycomacropeptide and amino acids supplements: A case report
|
Pinto, A. |
|
2017 |
13 |
C |
p. 105-110 6 p. |
artikel |
9 |
Dietary practices in propionic acidemia: A European survey
|
Daly, A. |
|
2017 |
13 |
C |
p. 83-89 7 p. |
artikel |
10 |
Elosulfase alfa enzyme replacement therapy attenuates disease progression in a non-ambulatory Japanese patient with Morquio A syndrome (case report)
|
Hiramatsu, Misako |
|
2017 |
13 |
C |
p. 76-79 4 p. |
artikel |
11 |
Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI: 10-Year follow up
|
Furujo, Mahoko |
|
2017 |
13 |
C |
p. 69-75 7 p. |
artikel |
12 |
First-year metabolic control guidelines and their impact on future metabolic control and neurocognitive functioning in children with PKU
|
de la Parra, Alicia |
|
2017 |
13 |
C |
p. 90-94 5 p. |
artikel |
13 |
Limitations of galactose therapy in phosphoglucomutase 1 deficiency
|
Nolting, Kristine |
|
2017 |
13 |
C |
p. 33-40 8 p. |
artikel |
14 |
Lipid profile in adult patients with Fabry disease - Ten-year follow up
|
Stepien, Karolina M. |
|
2017 |
13 |
C |
p. 3-6 4 p. |
artikel |
15 |
Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome
|
Eisengart, Julie B. |
|
2017 |
13 |
C |
p. 64-68 5 p. |
artikel |
16 |
Mitochondrial cardioencephalopathy due to a COQ4 mutation
|
Finsterer, Josef |
|
2017 |
13 |
C |
p. 7-8 2 p. |
artikel |
17 |
Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene
|
Finsterer, Josef |
|
2017 |
13 |
C |
p. 31-32 2 p. |
artikel |
18 |
Neonatal screening for biotinidase deficiency: A 30-year single center experience
|
Porta, Francesco |
|
2017 |
13 |
C |
p. 80-82 3 p. |
artikel |
19 |
Plasma fibroblast growth factor-21 levels in patients with inborn errors of metabolism
|
Kirmse, Brian |
|
2017 |
13 |
C |
p. 52-54 3 p. |
artikel |
20 |
Refining low protein modular feeds for children on low protein tube feeds with organic acidaemias
|
Daly, A. |
|
2017 |
13 |
C |
p. 99-104 6 p. |
artikel |
21 |
Role of AMPD2 in impaired glucose tolerance induced by high fructose diet
|
Hudoyo, Athanasius Wrin |
|
2017 |
13 |
C |
p. 23-29 7 p. |
artikel |
22 |
The cardiac glycoside convallatoxin inhibits the growth of colorectal cancer cells in a p53-independent manner
|
Anderson, Sarah E. |
|
2017 |
13 |
C |
p. 42-45 4 p. |
artikel |
23 |
The prevalence of diseases caused by lysosome-related genes in a cohort of undiagnosed patients
|
Vairo, Filippo Pinto |
|
2017 |
13 |
C |
p. 46-51 6 p. |
artikel |
24 |
The use of port-a-caths in adult patients with Lysosomal Storage Disorders receiving Enzyme Replacement Therapy-one centre experience
|
McLoughlin, Mairead |
|
2017 |
13 |
C |
p. 111-114 4 p. |
artikel |
25 |
Treating mitochondrial disorders requires full exploitation of available therapeutic options
|
Finsterer, Josef |
|
2017 |
13 |
C |
p. 97-98 2 p. |
artikel |
26 |
Type 3 Gaucher disease, diagnostic in adulthood
|
Detollenaere, Charles |
|
2017 |
13 |
C |
p. 1-2 2 p. |
artikel |
27 |
Weight loss induced by quetiapine in a 22q11.2DS patient
|
Demily, Caroline |
|
2017 |
13 |
C |
p. 95-96 2 p. |
artikel |